Navigation Links
Measuring Intracellular Enhanced Green Fluorescent Protein With the VersaFluor Fluorometer

Contributed by Jeff Wilson, and Andrew Segal, M.D., Genitrix, LLC, Cambridge, MA


Introduction
The Green Fluorescent Protein (GFP) derived from Aqueorius victoria has recently become a popular choice as a reporter gene. GFP can be used, for example, to study promoter function and to track the expression, localization, and function of proteins to which it has been recombinantly fused.1,2 When stimulated by light the molecule fluoresces without addition of any cofactors or substrates. For our studies we have used the Enhanced Green Fluorescent Protein gene (EGFP), a red-shifted variant of the wild-type protein, as a reporter gene in Jurkat cells. EGFP has an excitation maximum at 488 nm, and emission maximum at 507 nm. It is very resistant to photobleaching and is reported to maintain stable fluorescence from pH 7.0 to 11.5.3 In fluorometric assays, purified EGFP can be measured at concentrations in the low nanogram range.

In recent experiments we have shown that intracellular EGFP can be assayed using a VersaFluor fluorometer. Using the EX490/10 and EM510/10 filter set, we compared pEGFP-n2 transfected Jurkat cells with wild-type Jurkat cells. To approximate the amount of EGFP produced by transfected Jurkat cells, a standard curve with recombinant Enhanced Green Fluorescent Protein (rEGFP) was also generated. The methods and results from those experiments are reported here.


Methods
Jurkat cells (clone E6-1 from ATCC), a leukemic human T-cell line, were maintained in RPMI 1640 media with 2 mM L-glutamine and supplemented with 2.5 g/l glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, in addition to 10% fe tal bovine serum.

The enhanced green fluorescent protein vector pEGFP-n2 (Clontech Laboratories, Inc.) was transfected into Jurkat cells using a Gene Pulser II system with the Capacitance Extender Plus. The electroporation was conducted with a 0.4 cm cuvette with 310 volts and 950 F using 10 g of linearized pEGFP-n2 vector.4 Forty-eight hours post-transfection Jurkats were selected for neomycin resistance using G418 at a dose of 1 mg/ml. After 2 weeks, G418 was reduced to a concentration of 0.5 mg/ml.

Both untransfected and pEGFP-n2 transfected cells in exponential growth were harvested and washed twice with PBS (Phosphate Buffered Saline) and then suspended in PBS buffer. Viable cells were then counted by trypan blue exclusion using a hemacytometer and diluted to a concentration of 1.0 x 107 cells/ml. Cells from both groups were then diluted into 500 l aliquots at concentrations of 1.0 x 105, 3.16 x 105, 1.0 x 106, and 3.16 x 106 cells/ml. These values correspond to log con-centrations of 0.0, 0.5, 1.0, and 1.5 x 100,000 cells/ml, respectively.

Fluorescence was then measured using a VersaFluor fluorometer. An EX490/10 excitation filter was used in conjunction with an EM510/10 emission filter. The gain was set to medium and 250 l disposable microcuvettes were used. The instrument was zeroed with a 200 l sample of PBS buffer. After equilibrating at zero, the microcuvette was removed and a 200 l sample of 1.0 x 105 untransfected cells/ml was analyzed in a new microcuvette. After equilibrating for approximately 10 seconds, the relative fluorescent units (RFUs) were recorded and then the microcuvette was discarded. Then a 200 l sample of 3.16 x 105 untransfected ce lls/ml was analyzed. This procedure continued until each dilution of cells from both the pEGFP-n2 and wild-type Jurkat groups were analyzed once. Then, the fluorometer was re-zeroed, and duplicate measurements were taken for each dilution from both cell groups.

A standard curve using purified recombinant EGFP was then generated. To approximate the intracellular EGFP measured with the pEGFP-n2 transfected Jurkats, rEGFP (Clontech Laboratories, Inc.) was diluted into 1.0 x 105 wild-type Jurkat cells/ml at concentrations of 0, 1, 10, 100, and 1,000 ng/ml. Using the settings described above for the VersaFluor fluorometer, fluorescence was measured. A 200 l sample of wild-type Jurkat cells without rEGFP was zeroed and established as baseline. Then a sample with 1 ng/ml rEGFP was analyzed, followed by the 10, 100, and 1,000 ng/ml samples. This procedure was then repeated twice more, so that triplicate values were obtained for each concentration of rEGFP.


Results and Discussion
A standard curve with purified rEGFP was generated as shown in Figure 1. Although soluble EGFP is not a perfect quantitative standard for intracellular EGFP measurement, an estimation of intracellular EGFP can be made.

As shown in Figure 2, pEGFP-n2 transfected Jurkat cells exhibited considerably more fluorescence in the 505515 nm range than did wild-type Jurkat cells. Comparison of fluorescence on a log scale shows that both cell groups generated near linear intensity curves, with a difference in net fluorescence of approximately one log order.

If the net EGFP fluorescence is compared with the rEGFP standard curve in Figure 1, it is evident that the net fluoresce nce of pEGFP-n2 transfected Jurkats equates to approximately 10ng/ml rEGFP.

In conclusion, this experiment shows that the VersaFluor fluorometer can be used to assay for the presence of intracellular EGFP in intact, viable Jurkat cells.


References
1. Kain, S. R., Adams, M., Kondepudi A., Yang T. T., Ward, W. W., and Kitts, P., Biotechniques, 19, 650-655 (1995).

2. Ogawa, H., Inouye S., Tsuji, F. I., Yasuda, K., and Umesono K., PNAS, 92, 11899-11903 (1995).

3. Ward, W. W., personal communication

4. Barry, P., Pratte-Lowe, E., and Luciw, P., Bio-Rad Bulletin 1349


back to top
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Measuring multiple apoptosis parameters with the Agilent 2100 bioanalyzer
2. Measuring Gene Silencing Effects by RT-PCR Without RNA Isolation
3. Measuring RNase Activity A Real-time Kinetic Analysis
4. Measuring siRNA-mediated knockdown of IL-8 mRNA
5. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
6. Cis-Reporting System Monitors Intracellular Calcium Mobilization
7. Cis-Reporting System Monitors Intracellular Calcium Mobilization
8. Enhanced PCR Cloning System
9. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
10. Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR Performance
11. Enhanced siRNA Delivery and Long-term Gene Silencing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today announced that ... after the company changed focus to making analytical tools for biopharmaceutical quality control. ... technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson ...
(Date:4/19/2017)... ... April 19, 2017 , ... WHO: Peggy Lillis ... through education and advocacy. Founded in 2010 in memory of a single-parent mom ... foundation has become the most-consulted source for patient-focused information on C. diff infections ...
(Date:4/19/2017)... Calif. , April 19, 2017  As ... Drug Abuse and Heroin Summit ,  Proove® Biosciences, ... study analyzing genetics, environmental, and lifestyle factors to ... from the University of Southern California (USC), the ... , and Proove publish results showing that Proove ...
(Date:4/19/2017)... Mass. , April 19, 2017   ... results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) ... print issue of Critical Care Medicine . ... Mortality in Severe Sepsis Patients: Results From the ... use of the B·R·A·H·M·S PCT (procalcitonin) assay to ...
Breaking Biology Technology:
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):